<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2A2990B1-E1E1-4888-8848-7C256C3A3B43"><gtr:id>2A2990B1-E1E1-4888-8848-7C256C3A3B43</gtr:id><gtr:firstName>Adrian</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Mulholland</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FJ010588%2F1"><gtr:id>D3F2B727-59EF-4521-98F2-56B82D3A15A6</gtr:id><gtr:title>CCP-BioSim: Biomolecular simulation at the life sciences interface</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/J010588/1</gtr:grantReference><gtr:abstractText>Biomolecular simulation is a vibrant and growing area, making increasingly significant contributions to structural and systems biology. Physics-based simulations complement experiments in building a molecular level understanding of biology: they can test hypotheses and interpret and analyse experimental data in terms of interactions at the atomic level. A wide variety of simulation techniques have been developed, applicable to a range of different problems in biomolecular science. Simulations have already shown their worth in helping to analyse how enzymes catalyse biochemical reactions, and how proteins adopt their functional structures e.g. within cell membranes. They contribute to the design of drugs and catalysts, and in understanding the molecular basis of disease. Simulations have played a key role in developing the conceptual framework now at the heart of biomolecular science, that is, the understanding that the way that biological molecules move and flex - their dynamics - is central to their function. Developing methods from chemical physics and computational science will open exciting new opportunities in biomolecular science, including in drug design and development, biotechnology and biocatalysis. Much biomolecular simulation demands HPC resources: e.g. large-scale simulations of biological machines such as the ribosome, proton pumps and motors, membrane receptor complexes and even whole viruses. A particular challenge is the integration of simulations across length and timescales: different types of simulation method are required for different types of problems).

We propose to establish a new collaborative computational project in biomolecular simulation at the life sciences interface, CCP-BioSim. CCP-BioSim will be an inclusive wide-ranging project, bringing together chemists, physicists and chemical engineers as well as researchers from all branches of 'molecule-oriented' biochemistry and biology. Our aim will be to involve experimentalists and computational specialists, sharing the belief that the best science can be done when theory and experiment are closely integrated. We will invite all current CCPB members (more than 300) to join CCP-BioSim, and also any other researchers who are interested. Members will be informed of activities via the CCP-BioSim mailing list and the CCP-BioSim website. CCP-BioSim will aim to identify methodological and computational challenges in the field, and to foster develoments to meet these scientific challenges. Involvement of early career academics will also be an important goal: the training workshops we will run will help in establishing research groups. CCP-BioSim will also provide a networking and collaboration framework. The strategy will be to concentrate on activities that promote and facilitate high-impact biomolecular research. We will foster close and innovative interactions between computational and experimental scientists, encouraging integrated multidisciplinary studies. CCP-BioSim will develop and provide training and tools to lower the barrier to non-experts becoming proficient and productive users of biomolecular simulation techniques. We will also work to develop and apply advanced methods. Engagement with experimentalists is crucial to ensure that the methodologies delivered are relevant to biological problems. This is a rapidly developing field: the best science comes from new simulation techniques and state-of-the-art (especially high performance computing (HPC)) hardware and software, requiring methodological development and significant and varied software development effort, in the context of UK and international projects.</gtr:abstractText><gtr:potentialImpactText>Who will benefit from this research? 
As well as biosimulation specialists, a broad cross-section of bioscientists who are concerned, in some way or other, with the nature and behaviour of biomolecules at the atomic level. Eg: X-ray crystallographers, NMR Spectroscopists, Electron microscopists, Single-molecule biophysicists, Mass spectrometrists, Hydrodynamicists, Enzyme Kineticists, Medicinal Chemists, Chemical Biologists, Molecular Microbiologists.
The project will also help identify and develop the needs of the bio-community for high performance computing facilities. It will therefore benefit those bodies concerned with the development of the national and international roadmap for future HPC provision.
In the longer term, there is the potential for the project to impact on the general public through improvements in health and quality of life.

How will they benefit from this research?
The &amp;quot;molecule-oriented&amp;quot; bioscience community will benefit through access to tools, training, and trained simulation specialists that enable novel and more effective multidisciplinary projects where computational methods enhance and extend their core experimental approaches. Such integrated studies have a higher probability of producing high-impact discoveries and developments and so fostering such activities will enhance UK competitiveness in the international research arena. The CCP-BioSim project will provide tools and resources to facilitate this. These tools should give rise to major benefits (e.g. high-impact papers, major international grant awards) over the term of the project, and in future. In the longer term CCP-BioSim will be helping train a new generation of bioscientists who can work confidently and knowledgeably across the theory/experimental divide. What is 'state-of-the-art' today with regard to computational power and methodology, and so might be regarded as somewhat esoteric, will be on the desktop of any bioscientist in 5-10 years time. Impacts on the health and quality of life of the general public are likely to come primarily from the application of the methodologies fostered and disseminated by CCP-BioSim to drug design and discovery. Computational methods are already well-established in Pharma, since they can hasten and cheapen the process of drug discovery and development. The more computationally-intensive methods of biomolecular simulation are gaining ground, as improvements in computational power make accuracy and time-to-solution competitive with 'wet' methods. CCP-BioSim's activities will help improve this by a) helping train new generations of researchers with the necessary skills and b) providing a forum to enhance industrial-academic research links (members of the CCPB management group have established links with many large and smaller pharmaceutical/biotech companies, (AZ, Vernalis, Phaminox, GSK, Evotec, J&amp;amp;J, Pfizer...). The benefits to the public in the longer term come from new and/or cheaper medicinal products, plus the role that better computational methods have in addressing the 3Rs.

What will be done to ensure that they benefit from this research? 
CCP-BioSim activities are focussed precisely on ensuring this:
- The programme of workshops, co-organised with leading experimentalists in key disciplines, examining and fostering links across the simulation/experimental interface
- The annual conference focused on exemplifying and encouraging the highest quality interdisciplinary research.
- Training workshops introducing non-specialist bioscientists to high quality simulation methods, and specialists to the latest technological advances.
- Associated on-line training packages, available any time, any place.
- Training workshops and tools developed to aid access to HPC resources for those with a bioscience background.

Tools, software and data from development work will be made freely available, and disseminated via the website. Involvement of a wide community will ensure broad uptake.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2011-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>287541</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>13528180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Synthetic Biology Research Centre. BrisSynBio: Bristol Centre for Synthetic Biology</gtr:description><gtr:end>2019-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L01386X/1</gtr:fundingRef><gtr:id>99A34410-7E3E-4E97-8B69-AADEACAD8A12</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3053639</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biocatalysis and Biotransformation: A 5th Theme for the National Catalysis Hub</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/M013219/1</gtr:fundingRef><gtr:id>F56F04D2-ECEB-4AF7-95DD-239166412B65</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>CCP-BioSim was established in October 2011 with support from EPSRC to strengthen, promote and develop biomolecular simulation at the life sciences interface, an area that is increasingly contributing to biology, biocatalysis and important in drug design. We aim to identify methodological and computational challenges in this growing field, and develop links between academia and industry, and between theorists and experimentalists. CCP-BioSim received the top grade of 'Excellent' at mid-term review, with the Panel commenting &amp;quot;The management of the CCP has been excellent, the value for money has been outstanding to date, and this CCP has a real opportunity to put down a marker for UK science. The Widening Participation funding has also been put to excellent use. CCP-BioSim is an excellent example of a CCP supporting a growing community of researchers.&amp;quot; Since that review, we have refreshed our Management Group, and expanded our Advisory Board, building further links with industry (particularly the pharmaceutical industry). The Advisory Board has been expanded and refreshed for this renewal and consists of: Dr. Nicolas Foloppe (Vernalis plc, Chair); Dr. Colin Edge (GlaxoSmithKline); Dr. Mike King (UCB Pharmaceuticals); Dr. Mike Mazanetz (Evotec); Dr. Gary Tresadern (Johnson and Johnson Pharmaceuticals); Dr. Richard Ward (AstraZeneca); Prof. Modesto Orozco (IRB, Barcelona); Prof. Tony Watts, (Oxford, NMR); Dr. Pete Bond (A*STAR Bioinformatics Institute Singapore). The Management Group (current members listed in Part 1) has met eleven times since October 2011.
CCP-BioSim organizes training workshops and provides a framework for networking and collaboration. We develop and provide training and tools to lower the barrier to non-experts becoming proficient and productive users of biomolecular simulation techniques. We also work to develop and apply advanced methods, and engage with international activities (e.g. NSF, CECAM). We welcome new members across the whole community. We actively engage with structural and chemical biologists and industrial researchers through collaboration, dissemination and application of software, and invitations to conferences and workshops. We foster interactions between computational and experimental scientists, encouraging integrated multidisciplinary studies. We have a particular focus on multiscale modelling (e.g. in current flagship software development). Software tools have been made available via CCP-Forge. We are also developing tools for setting up and analysing biomolecular simulations. Outreach activities include hosting visits from experimental researchers, research visits to industrial partners, web-based training materials and research exemplars and presentations. CCP-BioSim also led a successful bid to EPSRC for a High End Computing Consortium in Biomolecular Simulation (hecbiosim.ac.uk). Working with CCP-BioSim, this Consortium helps bring HEC to a wider community, including non-traditional users and experimental bioscientists, and engage physical and computer scientists in biological applications.
Biomolecular simulations contribute to drug development (e.g. in structure-based drug design and predictions of metabolism), design of biomimetic catalysts, and in understanding the molecular bases of disease and drug resistance. Recent examples include simulations of biosensors and nanopores for DNA sequencing, and analysis of the causes of influenza resistance to Tamiflu. Advances in hardware and software now allow simulations on the microsecond (and even millisecond) timescale, enabling direct links with experiments. Simulations have proved crucial in analysing protein folding and mechanisms of biological catalysis. Developing methods from chemical physics and computational science will open new opportunities for new types and scales of application. A particular challenge is the integration of simulations of different types across length and timescales. We have developed a multiscale modelling approach for modelling drug metabolism by cytochrome P450 enzymes, spanning coarse-grained and atomistic molecular dynamics simulations, and reaction modelling using QM/MM methods. An essential aspect is the sharing of simulation data from different levels: we have developed scripts and procedures for conversion between the three different levels of simulation (available from ccpforge.cse.rl.ac.uk). We have applied this protocol to the most important human P450 in drug metabolism, CYP3A4, constructed and optimized a biologically realistic model of CYP3A4 in situ, simulated the dynamics of this complex, and modelled the oxidation of R-warfarin in the active site. The protocol that we have developed will be applicable to many other membrane-bound enzymes. Publications from the flagship project include: A multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymes PLoS Comput Biol. 10:e1003714; Trends in predicted chemoselectivity of cytochrome P450 oxidation. J Mol Graph Model. 52 30 (2014); QM/MM modelling of drug-metabolizing enzymes. Curr. Top. Med. Chem. 14, 1339 (2014); Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9. J. Am. Chem. Soc. 135, 8001 (2013). Effects of Dispersion in Density Functional Based Quantum Mechanical/Molecular Mechanical Calculations on Cytochrome P450 Catalyzed Reactions J. Chem. Theory Comput. 8, 4637-4645 (2012). A conformational landscape for alginate secretion across the outer membrane of Pseudomonas aeruginosa. Acta Crystallogr D Biol Crystallogr. 70, 2054 (2014); The role of 2-methyl-2, 4-pentanediol in sodium dodecyl sulfate micelle dissociation unveiled by dynamic light scattering and molecular dynamics simulations. Colloids Surf B Biointerfaces 114, 357 (2014). Dodecyl maltoside protects membrane proteins in vacuo. Biophys J. 105, 648 (2013); Structural model for the protein-translocating element of the twin-arginine transport system. PNAS USA 110 E1092-10101 (2013).</gtr:description><gtr:exploitationPathways>In CCP-BioSim, we plan for networking, training and conferences, industrial pilot projects and international engagement. We will expand our international and industrial engagement, as recommended by the mid-term review. We will build on our previous widening participation activities, and continue to work with other CCPs in areas of joint interest such as multiscale modelling (e.g. CCP5). We will also engage with the HEC BioSim Consortium to foster HEC applications (see HECBioSim.ac.uk).
1. Training workshops These will include existing workshops (e.g. analysis of biomolecular simulation data; how to set up a protein simulation; QM/MM methods; and protein-ligand docking), and new workshops on a wide variety of techniques (e.g. coarse-grained methods, metadynamics, Markov models, multiscale modelling). These workshops are held at institutions across the whole country, organized by specialists from the Management Group, and others. We have found high demand for these workshops, particularly from PhD students. A particular focus will be to introduce non-specialists, particularly early-stage researchers, to high-quality biomolecular simulation techniques. We will run certain core courses (e.g., how to set up protein MD simulations) annually, and others (e.g. QM/MM methods, docking) at least once every three years. We propose to develop new courses in response to community need (e.g. multiscale modelling, protein-protein docking, metadynamics, Monte Carlo methods, homology modelling; 'Markov Modeling' ER and Frank Noe, Berlin), and will include HEC training for bioscientists. We will maintain our policy of offering these workshops free to UK students and academics. They will also be open to industrial researchers at appropriate low cost; we will encourage industrial participation also through attracting industrial researchers to participate in delivering workshops, providing material and case studies, and using the workshops as a forum for potential employers. The Advisory Board will guide development of workshop material and content to ensure industrial relevance. Participation of software developers, both academic and commercial, will also be encouraged. An important aspect is provision of workshop material via the CCP-BioSim website, which we will extend significantly. Where appropriate, we will continue to work with other organizations (e.g. Molecular Graphics and Modelling Society, EPSRC CDTs, The Biochemical Society, IoP Biological Physics Group and other CCPs (e.g. with CCP5 on QM/MM, free energy, ChemShell and new computational architectures) to deliver joint workshops. 
2. Promoting links between experimentalists and computational scientists We propose a series of one-day workshops, aimed at fostering collaborations between experiment and biosimulation, with X-ray crystallography (e.g. with CCP4); NMR (with CCPN); cryo-electron microscopy (with CCP-EM, MW); single molecule biophysics (e.g. with IoP Biological Physics Group, SAH); and synthetic biology (e.g. with BrisSynBio, AJM). These workshops will also build links with experimental and industrial researchers. 
3. The annual conference We will continue the successful Frontiers of Biomolecular Simulation conference series (3-day event, typically 100 participants) (previously held in Nottingham, January 2007; Bristol 2008; York 2009; RAC Cirencester 2012; Nottingham 2013; Edinburgh, 2014; Leeds, 2015). This meeting, which is unique in Europe, attracts high quality speakers. The focus of the conference is methodological development and state-of-the-art applications, in particular high accuracy calculations of mechanisms, multi-level methods, and large-scale biomolecular simulations. Involvement of PhD students and early stage researchers will continue to be a focus, as will industrial involvement (previous conferences have attracted sponsorship from companies such as Syngenta, Accelrys, GSK and Clearspeed, and industrial speakers (e.g. AstraZeneca, Evotec, GSK, etc). 
4. Website development and outreach We will continue to develop the CCP-BioSim website (ccpbiosim.ac.uk) with increased accessibility and ease of use. The website will include increased emphasis on training material developed for our specialist workshops, and also (with our blog, ccpbiosim.tumblr.com) provide an interactive, collaborative space for user-generated content. This space will be used by the community to post questions, tutorials, simulation input files and conference announcements. The aim will be to provide a forum for interaction between computational experts, experimentalists, and students. This will ensure that simulation best practice is shared rapidly and provide a forum for discussion and collaboration. This will allow for the incubation of new ideas, thereby stimulating new project proposals and new collaborative science. Importantly, this will also aid in dissemination and public engagement: simulation 'movies' provide an intuitive and accessible picture of biomolecuar mechanisms e.g. elucidating antibiotic resistance. We will develop interactive simulation demos. Outreach: we will participate in outreach programmes to involve high school students in research, such as the in2science and the Nuffield Foundation schemes. We will seek to develop innovative approaches for outreach and public understanding, e.g. using interactive demos of biomolecular simulation. 
5. International engagement We will increase our international engagement, building on recommendations from mid-term review, and continue to coordinate with development of software workflow tools in other countries (e.g. our Sire/OpenMM development, etc.). We will contribute to issues of data standardization by seeking views from the community, defining requirements and challenges, and forming a point of contact for the UK biomolecular simulation community, coordinating with international activities. CAL is involved in the pyPCAZIP (for PCA analysis of MD simulations), a collaboration between the US-UK ExTASY project and the University of Barcelona; this was demoed at a CCP-BioSim training workshop in Bristol (Sept. 2014) and will be released in Oct. 2014; we will organize training workshops involving international participants. JWE and CAL are partners in two large EPSRC-NSF proposals to develop advanced software to facilitate the deployment of sophisticated biomolecular simulation methods in the context of advanced polarizable force fields and the exploitation of collective variables. CCP-BioSim will provide training in the software outputs from these projects. In addition, coordinated by JWE and CAL, CCP-BioSim representatives are attending the 'Conceptualization of an Institute for Biomolecular Simulations' workshops (https://sites.google.com/site/s2i2biomolecular/home) to formulate a proposal to NSF for such an Institute. In Europe, CCPBioSIm representatives participate in many CECAM workshops and in the development of CECAM strategy for computational science (e.g. SK and AJM participated in the CECAM workshop 'A Scientific Roadmap for Simulation and Modelling for 2020', Lugano Oct. 2013, and contributed to the resulting strategy document for Dominic Tildesley, CECAM Director. We will collaborate with international partners in organizing workshops (e.g. software development and training workshops at CECAM nodes, and workshops with the German Biophysical Society, CSCS, FEBS, EMBO). 
6. Industrial collaboration We will organize industry 'sandpits' to identify application areas and methods as targets for development and collaboration: in these meetings, challenges and problems from industry will be informally presented along with emerging methods; this will allow 'brain-storming' to help develop of new collaborations. We will also seek proposals for industrial pilot projects across the whole community; applications will be sought from the whole UK community. These will be awarded competitively, with impact and value for money judged by the Management Group. The aim will be to support research visits to industrial sites, to host research visits from industrial visitors, or other industry collaborations. 
7. Joint meetings with CCP5 on multiscale modelling methods We will continue our successful joint conference with CCP5 on multiscale methods (first in January 2014). We will also organize two-day training workshops in areas of joint interest with CCP5 (e.g. multiscale simulation, free energy methods), every other year . We will also seek to participate in activities with other CCPs, e.g. forthcoming joint conference with CCPN (2016)</gtr:exploitationPathways><gtr:id>79BA9EAE-ACC0-4377-A793-CC038D43F78B</gtr:id><gtr:sectors><gtr:sector>Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.ccpbiosim.ac.uk</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4276F6FE-C248-4B69-ACDD-E4CAA03BBB8D"><gtr:id>4276F6FE-C248-4B69-ACDD-E4CAA03BBB8D</gtr:id><gtr:title>QM/MM modelling of ketosteroid isomerase reactivity indicates that active site closure is integral to catalysis.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63564B0B-F598-413D-BC7E-9900E44EF02A"><gtr:id>63564B0B-F598-413D-BC7E-9900E44EF02A</gtr:id><gtr:title>Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2D2C7563-4A34-4574-AB77-B9BA019865E5"><gtr:id>2D2C7563-4A34-4574-AB77-B9BA019865E5</gtr:id><gtr:title>QM/MM modelling of drug-metabolizing enzymes.</gtr:title><gtr:parentPublicationTitle>Current topics in medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1568-0266</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B50D676-7FED-437D-B34C-EF510090BFA3"><gtr:id>0B50D676-7FED-437D-B34C-EF510090BFA3</gtr:id><gtr:title>The basis for carbapenem hydrolysis by class A ?-lactamases: a combined investigation using crystallography and simulations.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a72568245f3eb5d96b7b1672aeb34ebc"><gtr:id>a72568245f3eb5d96b7b1672aeb34ebc</gtr:id><gtr:otherNames>Fonseca F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C6399BA-4141-4927-8566-B4BB74BE7954"><gtr:id>7C6399BA-4141-4927-8566-B4BB74BE7954</gtr:id><gtr:title>Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5AEF66E6-B33F-4B0D-B434-717D3F3CBA4D"><gtr:id>5AEF66E6-B33F-4B0D-B434-717D3F3CBA4D</gtr:id><gtr:title>Conformational change and ligand binding in the aristolochene synthase catalytic cycle.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B50A3CBF-B456-4000-994A-A555D422CEB8"><gtr:id>B50A3CBF-B456-4000-994A-A555D422CEB8</gtr:id><gtr:title>Unraveling the role of protein dynamics in dihydrofolate reductase catalysis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/137e2978331d9bacd2bf41d6b654c949"><gtr:id>137e2978331d9bacd2bf41d6b654c949</gtr:id><gtr:otherNames>Luk LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95BA0CE6-7510-4A5F-B745-DD527FCE9F36"><gtr:id>95BA0CE6-7510-4A5F-B745-DD527FCE9F36</gtr:id><gtr:title>Combined quantum mechanics/molecular mechanics (QM/MM) simulations for protein-ligand complexes: free energies of binding of water molecules in influenza neuraminidase.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4227D513-3A62-4BBD-A062-2CB474280352"><gtr:id>4227D513-3A62-4BBD-A062-2CB474280352</gtr:id><gtr:title>Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89c5f635bc37f4387335cd425afa7aa8"><gtr:id>89c5f635bc37f4387335cd425afa7aa8</gtr:id><gtr:otherNames>Chudyk EI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8D4EC04-7CD0-4929-B3D3-A99C9EE3A4E5"><gtr:id>E8D4EC04-7CD0-4929-B3D3-A99C9EE3A4E5</gtr:id><gtr:title>Water Sites, Networks, And Free Energies with Grand Canonical Monte Carlo.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/16f70651b3532c9291786ccfdcd8d2f1"><gtr:id>16f70651b3532c9291786ccfdcd8d2f1</gtr:id><gtr:otherNames>Ross GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D426EDC-CB1D-4240-8A40-DC2A9416644E"><gtr:id>1D426EDC-CB1D-4240-8A40-DC2A9416644E</gtr:id><gtr:title>QM/MM simulations indicate that Asp185 is the likely catalytic base in the enzymatic reaction of HIV-1 reverse transcriptase</gtr:title><gtr:parentPublicationTitle>MedChemComm</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f57bb58b628193f80062706dcd5c20aa"><gtr:id>f57bb58b628193f80062706dcd5c20aa</gtr:id><gtr:otherNames>Rungrotmongkol T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7F12E2A-A8C8-493F-A703-FACB2E270861"><gtr:id>F7F12E2A-A8C8-493F-A703-FACB2E270861</gtr:id><gtr:title>Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B1B38DF1-BF38-463C-81B4-9A7FBA577ACE"><gtr:id>B1B38DF1-BF38-463C-81B4-9A7FBA577ACE</gtr:id><gtr:title>A catalytic role for methionine revealed by a combination of computation and experiments on phosphite dehydrogenase</gtr:title><gtr:parentPublicationTitle>Chem. Sci.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d3972a2fe576f5ce5a419b9f38af99e1"><gtr:id>d3972a2fe576f5ce5a419b9f38af99e1</gtr:id><gtr:otherNames>Ranaghan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/83894515-1904-41CC-A2D1-16E2CE9714B0"><gtr:id>83894515-1904-41CC-A2D1-16E2CE9714B0</gtr:id><gtr:title>Reaction mechanism of N-acetylneuraminic acid lyase revealed by a combination of crystallography, QM/MM simulation, and mutagenesis.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5a1dac39946fe339bf47f488f607f3a"><gtr:id>f5a1dac39946fe339bf47f488f607f3a</gtr:id><gtr:otherNames>Daniels AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53A15556-5421-4F21-8ABE-8B61C83752A7"><gtr:id>53A15556-5421-4F21-8ABE-8B61C83752A7</gtr:id><gtr:title>QM/MM simulations as an assay for carbapenemase activity in class A ?-lactamases.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89c5f635bc37f4387335cd425afa7aa8"><gtr:id>89c5f635bc37f4387335cd425afa7aa8</gtr:id><gtr:otherNames>Chudyk EI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5FB767D7-A7FC-4B20-917C-01B91FBBDFCD"><gtr:id>5FB767D7-A7FC-4B20-917C-01B91FBBDFCD</gtr:id><gtr:title>Elucidation of Nonadditive Effects in Protein-Ligand Binding Energies: Thrombin as a Case Study.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f4afa635f8a93da9732501fe25287bc"><gtr:id>0f4afa635f8a93da9732501fe25287bc</gtr:id><gtr:otherNames>Calabr? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39B7119D-964C-46F3-AF33-8FC3C7828541"><gtr:id>39B7119D-964C-46F3-AF33-8FC3C7828541</gtr:id><gtr:title>Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/33139F4B-7AA7-4203-8A21-762AB448C862"><gtr:id>33139F4B-7AA7-4203-8A21-762AB448C862</gtr:id><gtr:title>Effects of Dispersion in Density Functional Based Quantum Mechanical/Molecular Mechanical Calculations on Cytochrome P450 Catalyzed Reactions.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/26E947D3-F073-4398-9FDB-2C5A467D6339"><gtr:id>26E947D3-F073-4398-9FDB-2C5A467D6339</gtr:id><gtr:title>Determinants of reactivity and selectivity in soluble epoxide hydrolase from quantum mechanics/molecular mechanics modeling.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9B79258D-DB85-4499-B5D7-D15F6806FE9A"><gtr:id>9B79258D-DB85-4499-B5D7-D15F6806FE9A</gtr:id><gtr:title>High-level QM/MM calculations support the concerted mechanism for Michael addition and covalent complex formation in thymidylate synthase.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a4128e277c2102b7f5783974dddcdbc3"><gtr:id>a4128e277c2102b7f5783974dddcdbc3</gtr:id><gtr:otherNames>Kaiyawet N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12E8CED1-C129-4768-A521-C8F635130EB9"><gtr:id>12E8CED1-C129-4768-A521-C8F635130EB9</gtr:id><gtr:title>Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dae4f96b4cfddf91a29835a6fb7a9371"><gtr:id>dae4f96b4cfddf91a29835a6fb7a9371</gtr:id><gtr:otherNames>Lodola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D3156CA-DDD6-4097-ADAF-5820B23CB6B2"><gtr:id>5D3156CA-DDD6-4097-ADAF-5820B23CB6B2</gtr:id><gtr:title>Taking Ockham's razor to enzyme dynamics and catalysis.</gtr:title><gtr:parentPublicationTitle>Nature chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2d4ab7296ab4fb4689acfa0d1bce2aa"><gtr:id>e2d4ab7296ab4fb4689acfa0d1bce2aa</gtr:id><gtr:otherNames>Glowacki DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1755-4330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F7E9E5A-A993-4426-83F2-7D53BCD6647A"><gtr:id>3F7E9E5A-A993-4426-83F2-7D53BCD6647A</gtr:id><gtr:title>In pursuit of an accurate spatial and temporal model of biomolecules at the atomistic level: a perspective on computer simulation.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f516dd0f5d3b9fb06a2aa733c8ecdd2b"><gtr:id>f516dd0f5d3b9fb06a2aa733c8ecdd2b</gtr:id><gtr:otherNames>Gray A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8BE7573-EE22-41E8-AA83-E3B1D886244F"><gtr:id>C8BE7573-EE22-41E8-AA83-E3B1D886244F</gtr:id><gtr:title>Large-Scale Density Functional Theory Transition State Searching in Enzymes.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/879f80570b661acf297c717ba4b1fe71"><gtr:id>879f80570b661acf297c717ba4b1fe71</gtr:id><gtr:otherNames>Lever G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-7185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6D7B3B9A-BC1D-4D09-B4CC-21E88AC543E7"><gtr:id>6D7B3B9A-BC1D-4D09-B4CC-21E88AC543E7</gtr:id><gtr:title>A &amp;quot;Stepping Stone&amp;quot; Approach for Obtaining Quantum Free Energies of Hydration.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e16635058ad0725589a990fcc93cfab"><gtr:id>1e16635058ad0725589a990fcc93cfab</gtr:id><gtr:otherNames>Sampson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5EE475AB-1C35-4C63-ADA2-CF56E5242AC0"><gtr:id>5EE475AB-1C35-4C63-ADA2-CF56E5242AC0</gtr:id><gtr:title>Quantum Mechanics/Molecular Mechanics Modeling of Drug Metabolism: Mexiletine N-Hydroxylation by Cytochrome P450 1A2.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DDB6883A-C141-42F4-93B8-348995B19EBA"><gtr:id>DDB6883A-C141-42F4-93B8-348995B19EBA</gtr:id><gtr:title>Conformational effects on the pro-S hydrogen abstraction reaction in cyclooxygenase-1: an integrated QM/MM and MD study.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/771e813ec673acf96f31bcf62753f443"><gtr:id>771e813ec673acf96f31bcf62753f443</gtr:id><gtr:otherNames>Christov CZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3F5AE9C-7D41-413B-9C60-A2746648F805"><gtr:id>E3F5AE9C-7D41-413B-9C60-A2746648F805</gtr:id><gtr:title>A multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymes.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41762A7E-5640-4B4F-A9BC-700F488C4DF5"><gtr:id>41762A7E-5640-4B4F-A9BC-700F488C4DF5</gtr:id><gtr:title>FESetup: Automating Setup for Alchemical Free Energy Simulations.</gtr:title><gtr:parentPublicationTitle>Journal of chemical information and modeling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd37b25056de2e2d0ba8fc1649d88033"><gtr:id>bd37b25056de2e2d0ba8fc1649d88033</gtr:id><gtr:otherNames>Loeffler HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-9596</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3EB0ACB6-49B8-4052-A437-8D831248C850"><gtr:id>3EB0ACB6-49B8-4052-A437-8D831248C850</gtr:id><gtr:title>Comparison of ab Initio, DFT, and Semiempirical QM/MM Approaches for Description of Catalytic Mechanism of Hairpin Ribozyme.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e3fe2d5924ec77afc3c77004488de6bb"><gtr:id>e3fe2d5924ec77afc3c77004488de6bb</gtr:id><gtr:otherNames>Ml?nsk? V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42BC2D38-ADF9-4F97-96C0-28BE4AC734C5"><gtr:id>42BC2D38-ADF9-4F97-96C0-28BE4AC734C5</gtr:id><gtr:title>Mechanism of C-terminal intein cleavage in protein splicing from QM/MM molecular dynamics simulations.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cace1a5b287fc5df940d4b2061a68dd4"><gtr:id>cace1a5b287fc5df940d4b2061a68dd4</gtr:id><gtr:otherNames>Mujika JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/10C0D084-927E-408D-B29D-9EC09D2424C1"><gtr:id>10C0D084-927E-408D-B29D-9EC09D2424C1</gtr:id><gtr:title>Rapid decomposition and visualisation of protein-ligand binding free energies by residue and by water.</gtr:title><gtr:parentPublicationTitle>Faraday discussions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-6640</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE011F56-6010-4226-81CD-EB43FAEBAADF"><gtr:id>DE011F56-6010-4226-81CD-EB43FAEBAADF</gtr:id><gtr:title>Protein dynamics and enzyme catalysis: the ghost in the machine?</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2d4ab7296ab4fb4689acfa0d1bce2aa"><gtr:id>e2d4ab7296ab4fb4689acfa0d1bce2aa</gtr:id><gtr:otherNames>Glowacki DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55E0F8DD-9487-404B-B678-D975C2BD76B4"><gtr:id>55E0F8DD-9487-404B-B678-D975C2BD76B4</gtr:id><gtr:title>A practical guide to modelling enzyme-catalysed reactions.</gtr:title><gtr:parentPublicationTitle>Chemical Society reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0306-0012</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30438588-8BEC-4BB6-8A4B-644FAB6C0AFD"><gtr:id>30438588-8BEC-4BB6-8A4B-644FAB6C0AFD</gtr:id><gtr:title>Trends in predicted chemoselectivity of cytochrome P450 oxidation: B3LYP barrier heights for epoxidation and hydroxylation reactions.</gtr:title><gtr:parentPublicationTitle>Journal of molecular graphics &amp; modelling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/159e6d58a9d0758bf0066f354ce492ce"><gtr:id>159e6d58a9d0758bf0066f354ce492ce</gtr:id><gtr:otherNames>Rydberg P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1093-3263</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/251E2C8D-D372-4464-B4AE-9460FC52890D"><gtr:id>251E2C8D-D372-4464-B4AE-9460FC52890D</gtr:id><gtr:title>Role of active site residues in promoting cobalt-carbon bond homolysis in adenosylcobalamin-dependent mutases revealed through experiment and computation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/946dcf11ed80533ada0a6d42e3904c13"><gtr:id>946dcf11ed80533ada0a6d42e3904c13</gtr:id><gtr:otherNames>Rom?n-Mel?ndez GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/J010588/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>9EAAD5EA-2E54-4986-942F-2E204958FE29</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>High Performance Computing</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>